Association of proton‐pump inhibitor use with adverse health outcomes: a systematic umbrella review of meta‐analyses of cohort studies and randomised controlled …

SK Veettil, S Sadoyu, EM Bald… - British Journal of …, 2022 - Wiley Online Library
Aims The aim was to perform an umbrella review to summarise the existing evidence on
proton‐pump inhibitor (PPI) use and adverse outcomes and to grade the certainty of …

Proton pump inhibitors and the risk of community-acquired pneumonia: an updated meta-analysis

X Xun, Q Yin, Y Fu, X He… - Annals of …, 2022 - journals.sagepub.com
Background: Some studies suggested an increased risk of community-acquired pneumonia
(CAP) among proton pump inhibitors (PPI) users. However, the published evidence is …

The impact of proton pump inhibitors in liver diseases and the effects on the liver

YB Liu, MK Chen - Journal of Digestive Diseases, 2022 - Wiley Online Library
In this systematic and comprehensive overview, we aimed to evaluate the impact of proton
pump inhibitors (PPIs) on chronic liver diseases, especially on cirrhosis. A manual and …

A Prescribing Cascade of Proton Pump inhibitors following anticholinergic medications in older adults with dementia

SC Trenaman, A Harding, SK Bowles… - Frontiers in …, 2022 - frontiersin.org
Introduction: Prescribing cascade refers to use of a medication to treat a drug-related
adverse event. Prescribing cascades increase medication use, cost, and risk of adverse …

mind the gap–search and publication date of systematic reviews and meta‐analysis.

A Patel, P Spychalski, J Kobiela - Alimentary Pharmacology …, 2021 - search.ebscohost.com
Letter: mind the gap – search and publication date of systematic reviews and meta‐analysis
Page 1 730 | wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2021;54:730–732. © …

Commonly prescribed medications and risk of pneumonia and all-cause mortality in people with idiopathic pulmonary fibrosis: a UK population-based cohort study

AD Morgan, GM Massen, HR Whittaker, I Stewart… - 2023 - researchsquare.com
Background A growing body of evidence suggests that prolonged use of inhaled
corticosteroids (ICS) and proton pump inhibitors (PPIs) is associated with increased risks of …

[PDF][PDF] Association between the Use of Proton Pump Inhibitors with the Risk and the Prognosis of Breast Cancer: A Systematical Review

J Hu, W Hu, C Sun, C Cheng… - World J Surg …, 2021 - surgeryresearchjournal.com
Purpose: To evaluate the association between the uses of Proton Pump Inhibitors (PPIs) and
the risk of Breast Cancer (BC) before patients having a BC diagnose and explore the …

[PDF][PDF] Non-Prescription Use of Proton-Pump Inhibitors for Self-Treating Frequent Heartburn

S Memon, P Abbasi, MA Hingoro, AW Kalo… - Medical Forum …, 2022 - medforum.pk
Objective: Determine the Prescription Patterns of Proton Pump Inhibitors (PPI) at the
outpatient department (OPD) of a tertiary care hospital of Sindh. Study Design: Retrospective …

[PDF][PDF] INJUDICIOUS USE OF PROTON PUMP INHIBITORS ON IRREGULAR BASIS WITHOUT PRESCRIPTION–AN ALARMING SITUATION

S Shaikh, UA Soomro, MA Ata… - Journal of Peoples …, 2021 - publication.pumhs.edu.pk
ABSTRACT INTRODUCTION: Proton pump inhibitors (PPIs) are one of widely used drug
agents primarily indicated for the acid peptic disorders. OBJECTIVE: Determine the …

[HTML][HTML] Meta-analysis associates proton pump inhibitor use with higher pneumonia risk in cirrhotic patients: mining for “diamonds” in the coal

G Tziatzios, K Triantafyllou… - Annals of Gastroenterology, 2020 - ncbi.nlm.nih.gov
Defining a clinically well-focused and scientifically relevant question, together with the
application of strict inclusion/exclusion criteria, is of paramount importance when pursuing …